Basics Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests. IPO Date: September 20, 2017 Sector: Healthcare Industry: Medical Diagnostics & Research Market Cap: $471.81M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.96% Avg Daily Range (30 D): $0.25 | 2.20% Avg Daily Range (90 D): $0.31 | 2.97% Institutional Daily Volume Avg Daily Volume: .07M Avg Daily Volume (30 D): .1M Avg Daily Volume (90 D): .18M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 266 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $1.53M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.4M Avg Closing Trade (30 D): $.72M Avg Closing Trade (90 D): $1.84M Avg Closing Volume: 159.33K     News Feb 27, 2025 @ 3:04 PM Oncology Breakthroughs: How Cancer Research Is Adv... Source: Prnewswire Jun 3, 2024 @ 8:01 PM Celcuity To Participate in Jefferies Global Health... Source: Celcuity Inc. May 30, 2024 @ 11:36 AM Celcuity Announces Pricing of Underwritten Common ... Source: Celcuity Inc. May 30, 2024 @ 11:00 AM Celcuity Inc. Announces Plan to Initiate a Phase 3... Source: Celcuity Inc. May 15, 2024 @ 8:01 PM Celcuity Inc. Reports First Quarter Financial Resu... Source: Celcuity Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.05 $-.86 $-.87 Diluted EPS $-3.05 $-.86 $-.87 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -127.16M $ -37M $ -36.65M Operating Income / Loss $ -126.91M $ -36.13M $ -36.43M Cost of Revenue $ $ $ Net Cash Flow $ -14.74M $ -6.04M $ 9.91M PE Ratio